Yu X[Author] - Search Results

Year	Number of Results
1964	1
1966	1
1980	2
1981	3
1982	6
1983	3
1984	8
1985	11
1986	11
1987	18
1988	10
1989	25
1990	30
1991	38
1992	39
1993	53
1994	45
1995	46
1996	59
1997	75
1998	63
1999	100
2000	133
2001	126
2002	142
2003	194
2004	276
2005	336
2006	367
2007	458
2008	541
2009	629
2010	718
2011	868
2012	1071
2013	1277
2014	1519
2015	1771
2016	1787
2017	1950
2018	2106
2019	2573
2020	3110
2021	3476
2022	1884
2023	1

1

FTO mediates LINE1 m⁶A demethylation and chromatin regulation in mESCs and mouse development.

Wei J, Yu X, Yang L, Liu X, Gao B, Huang B, Dou X, Liu J, Zou Z, Cui XL, Zhang LS, Zhao X, Liu Q, He PC, Sepich-Poore C, Zhong N, Liu W, Li Y, Kou X, Zhao Y, Wu Y, Cheng X, Chen C, An Y, Dong X, Wang H, Shu Q, Hao Z, Duan T, He YY, Li X, Gao S, Gao Y, He C. Wei J, et al. Among authors: yu x. Science. 2022 May 27;376(6596):968-973. doi: 10.1126/science.abe9582. Epub 2022 May 5. Science. 2022. PMID: 35511947

2

Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities.

Li X, Wang H, Yu X, Saha G, Kalafati L, Ioannidis C, Mitroulis I, Netea MG, Chavakis T, Hajishengallis G. Li X, et al. Among authors: yu x. Cell. 2022 May 12;185(10):1709-1727.e18. doi: 10.1016/j.cell.2022.03.043. Epub 2022 Apr 27. Cell. 2022. PMID: 35483374

3

Borole/Borapyramidane Relationship.

Sun Q, Daniliuc CG, Yu X, Mück-Lichtenfeld C, Kehr G, Erker G. Sun Q, et al. Among authors: yu x. J Am Chem Soc. 2022 May 4;144(17):7815-7821. doi: 10.1021/jacs.2c01727. Epub 2022 Apr 19. J Am Chem Soc. 2022. PMID: 35438485

4

Retraction Notice to: Knockdown of KCNQ1OT1 Suppresses Cell Invasion and Sensitizes Osteosarcoma Cells to CDDP by Upregulating DNMT1-Mediated Kcnq1 Expression.

Qi X, Yu XJ, Wang XM, Song TN, Zhang J, Guo XZ, Li GJ, Shao M. Qi X, et al. Among authors: yu xj. Mol Ther Nucleic Acids. 2022 May 10;28:589. doi: 10.1016/j.omtn.2022.05.021. eCollection 2022 Jun 14. Mol Ther Nucleic Acids. 2022. PMID: 35614996 Free PMC article.

5

Synthesis and functional studies of self-adjuvanting multicomponent anti-HER2 cancer vaccines.

Feng Q, Yu X, Wang Y, Li S, Yang Y. Feng Q, et al. Among authors: yu x. RSC Adv. 2021 Oct 15;11(53):33814-33822. doi: 10.1039/d1ra06146a. eCollection 2021 Oct 8. RSC Adv. 2021. PMID: 35497522 Free PMC article.

6

tert-Butyloxycarbonyl-protected amino acid ionic liquids and their application to dipeptide synthesis.

Chen M, Yu X. Chen M, et al. Among authors: yu x. RSC Adv. 2021 Aug 13;11(44):27603-27606. doi: 10.1039/d1ra05597f. eCollection 2021 Aug 9. RSC Adv. 2021. PMID: 35480639 Free PMC article.

7

Hierarchical Structures in Macromolecule-Assembled Synthetic Cells.

Yu X, Zhou L, Wang G, Wang L, Dou H. Yu X, et al. Macromol Rapid Commun. 2022 Apr 20:e2100926. doi: 10.1002/marc.202100926. Online ahead of print. Macromol Rapid Commun. 2022. PMID: 35445490 Review.

8

Ketogenic Diets and Hepatocellular Carcinoma.

Lan Y, Jin C, Kumar P, Yu X, Lenahan C, Sheng J. Lan Y, et al. Among authors: yu x. Front Oncol. 2022 May 4;12:879205. doi: 10.3389/fonc.2022.879205. eCollection 2022. Front Oncol. 2022. PMID: 35600387 Free PMC article. Review.

9

Data-Driven Materials Innovation and Applications.

Wang Z, Sun Z, Yin H, Liu X, Wang J, Zhao H, Pang CH, Wu T, Li S, Yin Z, Yu X. Wang Z, et al. Among authors: yu x. Adv Mater. 2022 Apr 22:e2104113. doi: 10.1002/adma.202104113. Online ahead of print. Adv Mater. 2022. PMID: 35451528 Review.

10

Advances of podophyllotoxin and its derivatives: Patterns and mechanisms.

Shi RJ, Fan HY, Yu XH, Tang YL, Jiang J, Liang XH. Shi RJ, et al. Among authors: yu xh. Biochem Pharmacol. 2022 Jun;200:115039. doi: 10.1016/j.bcp.2022.115039. Epub 2022 Apr 15. Biochem Pharmacol. 2022. PMID: 35436465 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results